Embryo-maternal interactions at the implantation site:: a delicate equilibrium

被引:75
作者
Duc-Goiran, P [1 ]
Mignot, TM [1 ]
Bourgeois, C [1 ]
Ferré, F [1 ]
机构
[1] Univ Paris 05, INSERM U361, F-75014 Paris, France
关键词
implantation; blastocyst; endometrium; trophoblast; growth factors; cytokines; integrins; proteinases; interferons;
D O I
10.1016/S0301-2115(98)00310-8
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Blastocyst implantation and successful establishment of pregnancy require delicate interactions between the embryo and the maternal environment. During preimplantation, maternal/embryo communication is mediated by the trophectoderm, In the late luteal phase, physiological changes occur in the endometrium to allow blastocyst implantation. The "window of implantation" represents the period of maximum uterine receptivity for implantation. In response to signals from the embryo, pregnancy-specific proteins are released in maternal serum and a series of morphological, biochemical and immunological changes occur in the uterine environment. These systemic and local modifications can be considered to constitute "the maternal recognition of pregnancy". The human hemochorial placenta arises primarily through proliferation, migration and invasion of the endometrium and its vasculature by the embryonic trophoblast. The complex invasive processes accompanying implantation of the embryo are controlled at the embryo-maternal interface by factors from decidualized endometrium and the trophoblast itself. An inflammatory reaction and a proper maternal immune response allow survival and development of the fete-placental unit. In this review, we focus on interactions between trophoblast and uterine tissues and on cellular mechanisms and molecular signals involved in the closely regulated process of implantation. (C) 1999 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:85 / 100
页数:16
相关论文
共 109 条
[1]   A BOOSTER FOR CONTRACEPTIVE VACCINES [J].
ALDHOUS, P .
SCIENCE, 1994, 266 (5190) :1484-1486
[2]  
APLIN JD, 1991, J CELL SCI, V99, P681
[3]   EXPRESSION OF INTEGRIN ALPHA-6-BETA-4 IN HUMAN TROPHOBLAST AND ITS LOSS FROM EXTRAVILLOUS CELLS [J].
APLIN, JD .
PLACENTA, 1993, 14 (02) :203-215
[4]   DETECTION OF CYTOKINES (INTERLEUKIN-1, INTERLEUKIN-6, TRANSFORMING GROWTH-FACTOR-BETA) AND SOLUBLE TUMOR-NECROSIS-FACTOR RECEPTORS IN EMBRYO CULTURE FLUIDS DURING IN-VITRO FERTILIZATION [J].
AUSTGULEN, R ;
ARNTZEN, KJ ;
VATTEN, LJ ;
KAHN, J ;
SUNDE, A .
HUMAN REPRODUCTION, 1995, 10 (01) :171-176
[5]   HUMAN CYTOTROPHOBLAST INVASION IS UP-REGULATED BY EPIDERMAL GROWTH-FACTOR - EVIDENCE THAT PARACRINE FACTORS MODIFY THIS PROCESS [J].
BASS, KE ;
MORRISH, D ;
ROTH, I ;
BHARDWAJ, D ;
TAYLOR, R ;
ZHOU, Y ;
FISHER, SJ .
DEVELOPMENTAL BIOLOGY, 1994, 164 (02) :550-561
[6]  
BERGH PA, 1992, FERTIL STERIL, V58, P537
[7]   UTERINE EXPRESSION OF LEUKEMIA INHIBITORY FACTOR COINCIDES WITH THE ONSET OF BLASTOCYST IMPLANTATION [J].
BHATT, H ;
BRUNET, LJ ;
STEWART, CL .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (24) :11408-11412
[8]   Expression of heparin-binding epidermal growth factor messenger RNA in the human endometrium [J].
Birdsall, Mary A. ;
Hopkisson, James F. ;
Grant, Kate E. ;
Barlow, David H. ;
Mardon, Helen J. .
MOLECULAR HUMAN REPRODUCTION, 1996, 2 (01) :31-34
[9]  
Bischof P, 1995, Early Pregnancy, V1, P263
[10]  
BISCHOF P, 1995, MOL HUM REPROD, V10, P734